Control high-cost drug spend without restricting access
Design coverage strategies for high-cost therapies
Build step therapy and prior authorization frameworks
Align access with formulary and rebate strategy
Identify opportunities for biosimilars and alternatives
Balance clinical outcomes with financial sustainability
Control high-cost drug spend without restricting access
Design coverage strategies for high-cost therapies
Build step therapy and prior authorization frameworks
Align access with formulary and rebate strategy
Identify opportunities for biosimilars and alternatives
Balance clinical outcomes with financial sustainability